NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

IF only FLOPPER had a leg left to stand on…

Here is the ENTIRETY of my OTLK posts in chronological order

VS FLOPPER’s cherry picking HYPERBOLIC same ole same ole’s war of words:

maverick_1
Re: None
Tuesday, May 31, 2022 8:36:39 AM
Post# of 733 maverick_1
Fortunately I sold and took a small loss!:

8:27a ET 5/31/2022 - Dow Jones
Outlook Therapeutics Withdraws Wet AMD Treatment Application
Mentioned: OTLK

By Will Feuer

Outlook Therapeutics Inc. said it has voluntarily withdrawn its biologics license application for its experimental wet age-related macular degeneration treatment while it responds to the U.S. Food and Drug Administration's request for additional information.

The company said it plans to re-submit a revised application for its experimental treatment, called ONS-5010, or bevacizumab-vikg, by September.

"We are continuing to have productive discussions with the FDA and are committed to providing the additional information necessary to support the application," Chief Executive Russell Trenary said. "We look forward to a successful resubmission and ultimately the potential approval of ONS-5010 for the treatment of wet AMD."

Shares of Outlook Therapeutics tumbled almost 38% to $1.05 in premarket trading.

ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration and other retinal diseases, Outlook Therapeutics said.

Some 1.8 million Americans aged 40 years and older are affected by age-related macular degeneration, according to the U.S. Centers for Disease Control and Prevention. Age-related macular degeneration is the leading cause of permanent impairment of reading and fine or close-up vision among people aged 65 years and older, the agency says.

DIFFERENT STROKES for DIFFERENT FOLKS

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169010666



maverick_1
Re: maverick_1 post# 495
Tuesday, March 28, 2023 7:52:18 AM
Post# of 733
Can eyes revived after death open the door to advances for age-related macular degeneration, glaucoma and other major causes of blindness? The Future of Everything looks at a new leap in efforts to restore lost vision.


https://www.wsj.com/articles/a-spark-of-life-after-death-points-to-new-hope-for-blindness-11662303872


maverick_1
Re: maverick_1 post# 578
Thursday, August 24, 2023 10:51:09 AM
Post# of 733
When a 500k block from HF was announced BEFORE PDUFCA that should have stated the OBVIOUS along with the fact that this sector is exceptionally high high risk.

ADDITIONALLY Likely more $ needed re qtrly burn rate.

Moreover OTLK is competing with strongman Eyelea REGN who overcame in JUNE 2023 FDA’s CRL on a higher dosage!

Just look at KOD’s massive cratering even tho for Diabetic.

Even Institutional investors have been buried in this sector except for darling REGN.

Posted Sweet Nothings are just that!

DIFFERENT STROKES for DIFFERENT FOLKS

thermo
08/24/23 12:15 PM
#628 RE: maverick_1 #626
okay, a mile wide and an inch deep.



maverick_1
08/30/23 10:46 AM
#644 RE: maverick_1 #626
Hate to say it but this did not pass my smell test (see prior posts).
Fortunately I sold ALL & took a load vs a LARGE one.

Was going to post more about it .

—————————————

USELESS to bother as it’s all about his 34,000 posts in 10 yrs on ONE company &
never being on the right side of NWBO HISTORY & WITHOUT links to his HERESAYS to
corall his audience.

For Others without the decade long experience & WHEREWITHAL It may be different.

The never ending circus here vs moving FORWARD.